Samriddhi S. Gupte

Samriddhi S. Gupte

Auto-generated profile, based on publicly available information

Samriddhi S. Gupte

Max Institute for Healthcare Management, Indian School of Business , Hyderabad

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
SCShekhar Chauhan
Shekhar Chauhan
SGSamriddhi S. Gupte
Samriddhi S. Gupte
SKShubham Kumar
Shubham Kumar
RPRatna Patel
Ratna Patel

4 July 2021 in Journal of Substance Use
Verified
Journal Article
Closed access
SKShubham Kumar
Shubham Kumar
RPRatna Patel
Ratna Patel
SCShekhar Chauhan
Shekhar Chauhan
SGSamriddhi S. Gupte
Samriddhi S. Gupte
There has been a comparative decline in tobacco consumption; however, India still has the highest number of tobacco consumers in terms of absolute numbers.This study aimed to examine the prevalence...

9 October 2024 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
SGSamriddhi S Gupte
Samriddhi S Gupte
ASAshish Sachdeva
Ashish Sachdeva
AKAman Kabra
Aman Kabra
BSBhanu Pratap Singh
Bhanu Pratap Singh
AKAshish Krishna
Ashish Krishna
SDSarang Deo
Sarang Deo
Hypertension poses a critical threat to health in India, being the predominant risk factor for mortality and disability. With over 70% of outpatient care being provided by the private sector, our study investigated the practices and incentives of private health providers in screening, diagnosing, treating, monitoring, and counseling hypertension patients in rural and peri-urban India. Conducted from April 2020 to February 2021, the qualitative study involved 46 participants, including various healthcare professionals and patients in three Telangana state districts. Analysis revealed a lack of recognition of hypertension’s gravity among private providers in these areas, leading to inconsistent screening practices and varied diagnostic thresholds, particularly among rural medical practitioners. Both formal and informal providers lacked standardized protocols and follow-up mechanisms, with limited technical knowledge about hypertension observed, especially among rural practitioners who were often the first point of contact. Drug effectiveness, and incentives from pharmaceutical sales representatives influenced prescribing practices. Diagnostic labs also offered financial incentives for patient referrals. Thus, aligning providers’ objectives with patient preferences and public health goals is crucial. To encourage evidence-based hypertension care, the government and NGOs could implement strategies such as tailored incentives, financial rewards, tax benefits, accreditation, and recognition for private healthcare providers. Professional bodies in the private sector should establish programs emphasizing quality assurance and certifications. Future research should focus on designing and testing new models for private sector hypertension service delivery, coupled with targeted interventions to enhance care in rural and peri-urban settings.

28 February 2023
Verified
Book Chapter
Closed access
PDF file
ASAkancha Singh
Akancha Singh
SGSamriddhi S. Gupte
Samriddhi S. Gupte
ACAparajita Chattopadhyay
Aparajita Chattopadhyay

1 January 2023
Verified
Book
Closed access
ACAparajita Chattopadhyay
Aparajita Chattopadhyay
ASAkancha Singh
Akancha Singh
SGSamriddhi S. Gupte
Samriddhi S. Gupte